Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Levy Richard S
Relationship:  
City:   Wilmington
State:   DE
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   67,748    

Indirect Shares

   0      
Direct Value   $3,665,949    

Indirect Value

   $0      
Total Shares   67,748      
Total Value   $3,665,949      


Incyte Corp $985,093 Madrigal Pharmaceuticals Inc $2,420,648 Protara Therapeutics, Inc $92,690 Kodiak Sciences Inc. $3,260 Kiniksa Pharmaceuticals, Ltd. $164,257 Incyte Corp $985,093 Madrigal Pharmaceuticals Inc $2,420,648 Protara Therapeutics, Inc $92,690 Kodiak Sciences Inc. $3,260 Kiniksa Pharmaceuticals, Ltd. $164,257
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   195.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY EVP, Chief Drug Dev Of... 2016-01-06 16,926 2010-03-15 0    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-04-01 10,298 2017-08-21 0    Premium*  
            Protara Therapeutics, Inc TARA Director 2020-01-10 31,000 2020-01-10 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-03-20 1,000 2020-03-20 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-05-03 8,524 2023-06-29 0    Premium*  
* Premium Members only  

Records found :    81         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-09-16 4 AS $47.58 $380,640 D/D (8,000) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-10-16 4 AS $49.03 $392,240 D/D (8,000) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-10-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-10-23 4 OE $3.11 $43,241 D/D 13,904 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-11-17 4 OE $14.72 $176,640 D/D 12,000 30,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-11-17 4 AS $69.97 $839,640 D/D (12,000) 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-12-16 4 AS $72.36 $868,320 D/D (12,000) 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-12-16 4 OE $14.72 $176,640 D/D 12,000 30,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-01-06 4 OE $18.32 $458,000 D/D 25,000 43,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-01-06 4 AS $71.84 $1,796,000 D/D (25,000) 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-01-08 4 A $0.00 $0 D/D 3,022 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-01-16 4 OE $14.72 $176,640 D/D 12,000 30,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-01-16 4 AS $73.07 $876,840 D/D (12,000) 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-02-06 4 OE $18.32 $458,000 D/D 25,000 43,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-02-06 4 AS $75.11 $1,877,750 D/D (25,000) 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-02-17 4 AS $76.90 $922,800 D/D (12,000) 18,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2015-02-17 4 OE $14.72 $187,947 D/D 12,000 30,205 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-03-06 4 OE $18.32 $458,000 D/D 25,000 46,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-03-06 4 AS $89.91 $2,247,750 D/D (25,000) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-04-06 4 OE $18.32 $458,000 D/D 25,000 46,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-04-06 4 AS $88.77 $2,219,250 D/D (25,000) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-05-06 4 AS $99.43 $736,975 D/D (7,412) 21,227 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-05-06 4 OE $18.32 $135,788 D/D 7,412 28,639 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-08 4 OE $18.32 $72,126 D/D 3,937 25,164 0 -
INCY Incyte Corp EVP, Chief Drug Dev Officer   •       –      –    2015-06-08 4 AS $107.58 $423,542 D/D (3,937) 21,227 0 -
  81  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us